Doxecitine–doxribtimine for treating thymidine kinase 2 deficiency in people of any age [ID6484]

  • In development
  • GID-HST10063
  • Expected publication date: 

Documents

Documents created during the development process.

Invitation to participate

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6484

Referral

Referral

Topic selection